These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 6947407)

  • 21. Value of inhaled antibiotics in cystic fibrosis patients.
    Wunderlich P; Paul KD; Wehner J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):34-6. PubMed ID: 2130713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial chemotherapy in patients with cystic fibrosis.
    Guggenbichler JP; Schneeberger J
    Infection; 1987; 15(5):397-402. PubMed ID: 3692614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of the efficacy and safety of azlocillin and gentamicin in the treatment of serious infections.
    del Rosal PL
    J Antimicrob Chemother; 1983 May; 11 Suppl B():159-67. PubMed ID: 6352599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative clinical evaluation of azlocillin and gentamicin.
    Sabbaj J; Torres M; Loza L
    J Antimicrob Chemother; 1983 May; 11 Suppl B():175-81. PubMed ID: 6619027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of Pseudomonas aeruginosa infections].
    Bergan T
    Tidsskr Nor Laegeforen; 1969 Oct; 89(19):1495-8. PubMed ID: 4986547
    [No Abstract]   [Full Text] [Related]  

  • 26. Microbiologic and therapeutic aspects of Staphylococcus aureus in cystic fibrosis patients.
    Bauernfeind A; Hörl G; Przyklenk B
    Scand J Gastroenterol Suppl; 1988; 143():99-102. PubMed ID: 3164518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance of Pseudomonas aeruginosa infections in a Children's hospital.
    Abbe JS; Moffet HL
    Antimicrob Agents Chemother (Bethesda); 1970; 10():303-8. PubMed ID: 5000261
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum bactericidal test as a prognostic indicator in acute pulmonary exacerbations of cystic fibrosis.
    Cahen P; Le Bourgeois M; Delacourt C; Coustère C; Nicaise P; de Blic J; Véron M; Scheinmann P; Gaillard JL
    Pediatrics; 1993 Feb; 91(2):451-5. PubMed ID: 8424026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intravenous administration of antibiotics in the treatment of cystic fibrosis].
    Vávrová V; Lochmann O; Suková B; Copová M; Zapletal A; Absolonová V; Houstĕk J
    Cesk Pediatr; 1986 Oct; 41(10):605-7. PubMed ID: 3502950
    [No Abstract]   [Full Text] [Related]  

  • 30. Nebulized gentamicin in children and adolescents with cystic fibrosis.
    Kun P; Landau LI; Phelan PD
    Aust Paediatr J; 1984 Mar; 20(1):43-5. PubMed ID: 6466215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
    Kernen Y; Sauty A; Roulet M
    Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
    Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-pseudomonas activity of azlocillin during pulmonary infection in patients with cystic fibrosis.
    Levy J; Baran D; Klastersky J
    J Antimicrob Chemother; 1982 Sep; 10(3):235-8. PubMed ID: 6815156
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
    Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
    Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of Pseudomonas sepsis in mice with azlocillin combined with gentamicin.
    Polívková L; Holá V
    Czech Med; 1986; 9(4):200-2. PubMed ID: 3102185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled trial of aztreonam vs. tobramycin and azlocillin for acute pulmonary exacerbations of cystic fibrosis.
    Bosso JA; Black PG
    Pediatr Infect Dis J; 1988 Mar; 7(3):171-6. PubMed ID: 3128767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of pseudomonas infection with the new ureidopenicillin, azlocillin (author's transl)].
    Helm EB; Ristow W; Shah PM; Schacht P; Stille W
    Dtsch Med Wochenschr; 1977 Aug; 102(34):1211-6. PubMed ID: 913249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
    Konopka CA
    Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin.
    Conway SP; Miller MG; Ramsden C; Littlewood JM
    Acta Paediatr Scand; 1985 Jan; 74(1):107-13. PubMed ID: 3885674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.